Lynn Seely - Insider Trading & Ownership

Entity
Individual
Location
501 2 Nd Street, Suite 211, San Francisco, California
Summary
The estimated net worth of Lynn Seely is at least $1.85 M dollars as of June 14, 2024. Lynn Seely is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $1.39 M. Lynn Seely is the President and CEO, Director of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $456 K.
All Insider Reports
All Insider Reports

Ownership of Lynn Seely

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Director $1.39 M Jun 12, 2024
LYEL Lyell Immunopharma, Inc. President and CEO, Director $456 K Feb 9, 2024

Insider Transactions Reported by Lynn Seely:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership